Works matching IS 13889842 AND DT 2022 AND VI 24
Results: 375
Issue Information.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. i, doi. 10.1002/ejhf.2425
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitors: efficacious and safe in elderly patients with heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2305, doi. 10.1002/ejhf.2744
- By:
- Publication type:
- Article
Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2238, doi. 10.1002/ejhf.2741
- By:
- Publication type:
- Article
Guideline‐directed medical therapy improves not only left but also right heart function.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2235, doi. 10.1002/ejhf.2739
- By:
- Publication type:
- Article
Health‐related quality of life outcomes in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2264, doi. 10.1002/ejhf.2738
- By:
- Publication type:
- Article
Reply to 'Morphine use in acute cardiogenic pulmonary oedema: is MIMO trial enough to change practice?'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2393, doi. 10.1002/ejhf.2734
- By:
- Publication type:
- Article
The dangerous liaison between epicardial adipose tissue and heart failure with preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2261, doi. 10.1002/ejhf.2733
- By:
- Publication type:
- Article
How can sodium–glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron‐deficient? Implications for understanding iron homeostasis in heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2287, doi. 10.1002/ejhf.2731
- By:
- Publication type:
- Article
Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2307, doi. 10.1002/ejhf.2722
- By:
- Publication type:
- Article
Morphine use in acute cardiogenic pulmonary oedema: is MIMO trial enough to change practice? Letter regarding the article 'Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open‐label, randomized controlled trial'
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2392, doi. 10.1002/ejhf.2724
- By:
- Publication type:
- Article
Right ventricular dysfunction in patients with new-onset heart failure: longitudinal follow-up during guideline-directed medical therapy.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2226, doi. 10.1002/ejhf.2721
- By:
- Publication type:
- Article
Reply to the letter regarding the article 'Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2391, doi. 10.1002/ejhf.2717
- By:
- Publication type:
- Article
Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS‐HFpEF study.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2251, doi. 10.1002/ejhf.2709
- By:
- Publication type:
- Article
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2297, doi. 10.1002/ejhf.2707
- By:
- Publication type:
- Article
Non‐intuitive findings from the MEMS‐HF haemodynamic substudy.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2331, doi. 10.1002/ejhf.2705
- By:
- Publication type:
- Article
Letter regarding the article 'Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2391, doi. 10.1002/ejhf.2701
- By:
- Publication type:
- Article
Diagnostic performance of microRNAs in the detection of heart failure with reduced or preserved ejection fraction: a systematic review and meta‐analysis.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2212, doi. 10.1002/ejhf.2700
- By:
- Publication type:
- Article
Reply to the letter regarding the article 'Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2390, doi. 10.1002/ejhf.2692
- By:
- Publication type:
- Article
How prevalent is cardiac amyloidosis and which patients should be screened?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2352, doi. 10.1002/ejhf.2685
- By:
- Publication type:
- Article
Letter regarding the article 'Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2390, doi. 10.1002/ejhf.2679
- By:
- Publication type:
- Article
Diagnosing heart failure with preserved ejection fraction in cardiac amyloidosis or diagnosing cardiac amyloidosis in heart failure with preserved ejection fraction?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2387, doi. 10.1002/ejhf.2678
- By:
- Publication type:
- Article
Unravelling the role of sex in the pathophysiology, phenotypic expression and diagnosis of cardiac amyloidosis.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2364, doi. 10.1002/ejhf.2674
- By:
- Publication type:
- Article
The rise of devices in heart failure with preserved ejection fraction: the future is not set.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2285, doi. 10.1002/ejhf.2667
- By:
- Publication type:
- Article
Value of the HFA‐PEFF and H<sub>2</sub>FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2374, doi. 10.1002/ejhf.2616
- By:
- Publication type:
- Article
Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2367, doi. 10.1002/ejhf.2658
- By:
- Publication type:
- Article
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2342, doi. 10.1002/ejhf.2532
- By:
- Publication type:
- Article
Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2355, doi. 10.1002/ejhf.2646
- By:
- Publication type:
- Article
Kong LY, Cui XZ, Ma RC, Li L, Xiang W, Wang XJ, Liu F. Primary pericardial angiosarcoma in a patient with a history of colon carcinoma. Eur. J. Heart Fail. 2022. https://doi.org/10.1002/ejhf.2623.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2395, doi. 10.1002/ejhf.2623
- Publication type:
- Article
Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM‐HFpEF).
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2275, doi. 10.1002/ejhf.2619
- By:
- Publication type:
- Article
Effects of remote haemodynamic‐guided heart failure management in patients with different subtypes of pulmonary hypertension: insights from the MEMS‐HF study.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2320, doi. 10.1002/ejhf.2656
- By:
- Publication type:
- Article
Device‐based remote monitoring strategies for congestion‐guided management of patients with heart failure: a systematic review and meta‐analysis.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2333, doi. 10.1002/ejhf.2655
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. i, doi. 10.1002/ejhf.2425
- Publication type:
- Article
December 2022 at a glance: heart failure with preserved ejection fraction, sodium–glucose cotransporter 2 inhibitors and cardiac amyloidosis.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2209, doi. 10.1002/ejhf.2244
- By:
- Publication type:
- Article
From Forgotten to Rediscovered: shifting focus to the Right Ventricle in Primary Mitral Regurgitation.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2172, doi. 10.1002/ejhf.2730
- By:
- Publication type:
- Article
Outpatient versus inpatient intravenous diuretic therapy for heart failure in the United States.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2199, doi. 10.1002/ejhf.2727
- By:
- Publication type:
- Article
Association between heart failure quality of care and mortality: a population‐based cohort study using nationwide registries.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2066, doi. 10.1002/ejhf.2725
- By:
- Publication type:
- Article
Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: an analysis from the Look AHEAD trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2037, doi. 10.1002/ejhf.2723
- By:
- Publication type:
- Article
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2029, doi. 10.1002/ejhf.2720
- By:
- Publication type:
- Article
Reply to the letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2207, doi. 10.1002/ejhf.2719
- By:
- Publication type:
- Article
Heart failure with preserved ejection fraction in China: an urgent need for improving the management.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2063, doi. 10.1002/ejhf.2718
- By:
- Publication type:
- Article
Implementing the evidence – the true summit of evidence‐based care and the false peak of guidelines.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2090, doi. 10.1002/ejhf.2712
- By:
- Publication type:
- Article
Chronic kidney disease (CKD) and CKD‐ism in heart failure – what a mess!
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2196, doi. 10.1002/ejhf.2696
- By:
- Publication type:
- Article
Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2207, doi. 10.1002/ejhf.2694
- By:
- Publication type:
- Article
Reply to 'The 50 shades of bilirubin'. Letter regarding the article 'Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HF'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2206, doi. 10.1002/ejhf.2683
- By:
- Publication type:
- Article
Don't tell your patients where they are, let them tell you.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2105, doi. 10.1002/ejhf.2682
- By:
- Publication type:
- Article
The 50 shades of bilirubin. Letter regarding the article 'Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HF'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2206, doi. 10.1002/ejhf.2671
- By:
- Publication type:
- Article
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2000, doi. 10.1002/ejhf.2669
- By:
- Publication type:
- Article
Obstructive coronary artery disease, a common and curable but critical comorbidity in acute decompensated heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2150, doi. 10.1002/ejhf.2665
- By:
- Publication type:
- Article
Right ventricular dysfunction predicts outcome after transcatheter mitral valve repair for primary mitral valve regurgitation.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2162, doi. 10.1002/ejhf.2661
- By:
- Publication type:
- Article
Heart failure with supra‐normal left ventricular ejection fraction: distinct polygenic bases of an unrecognized phenotype.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2128, doi. 10.1002/ejhf.2657
- By:
- Publication type:
- Article